These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 10189383)

  • 21. Expression and prognostic significance of the inhibitor of apoptosis protein (IAP) family and its antagonists in chronic lymphocytic leukaemia.
    Grzybowska-Izydorczyk O; Cebula B; Robak T; Smolewski P
    Eur J Cancer; 2010 Mar; 46(4):800-10. PubMed ID: 20045309
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
    Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
    Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antigen modulation followed by quantitative flow cytometry of B-chronic lymphocytic leukemia cells after treatment.
    Kusenda J; Babusíková O
    Neoplasma; 2004; 51(2):97-102. PubMed ID: 15190418
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interleukin-8 induces the accumulation of B-cell chronic lymphocytic leukemia cells by prolonging survival in an autocrine fashion.
    Francia di Celle P; Mariani S; Riera L; Stacchini A; Reato G; Foa R
    Blood; 1996 May; 87(10):4382-9. PubMed ID: 8639799
    [TBL] [Abstract][Full Text] [Related]  

  • 25. B-chronic lymphocytic leukemia. Disease progression in 150 untreated stage A and B patients as predicted by bone marrow pattern.
    Pangalis GA; Boussiotis VA; Kittas C
    Nouv Rev Fr Hematol (1978); 1988; 30(5-6):373-5. PubMed ID: 3222147
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of trisomy 12 by fluorescence in situ hybridization in peripheral blood, bone marrow and lymph nodes of patients with B-cell chronic lymphocytic leukemia.
    Liso V; Capalbo S; Lapietra A; Pavone V; Guarini A; Specchia G
    Haematologica; 1999 Mar; 84(3):212-7. PubMed ID: 10189384
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunophenotypic characterization of the leukemic B-cells from Iranian patients with chronic lymphocytic leukemia: association between CD38 expression and disease progression.
    Hojjat Farsangi M; Jeddi-Tehrani M; Razavi SM; Sharifian RA; Shamsian Khoramabadi A; Rabbani H; Shokri F
    Iran J Immunol; 2008 Mar; 5(1):25-35. PubMed ID: 18319522
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disease-related anemia in chronic lymphocytic leukemia is not due to intrinsic defects of erythroid precursors: a possible pathogenetic role for tumor necrosis factor-alpha.
    Tsopra OA; Ziros PG; Lagadinou ED; Symeonidis A; Kouraklis-Symeonidis A; Thanopoulou E; Angelopoulou MK; Vassilakopoulos TP; Pangalis GA; Zoumbos NC
    Acta Haematol; 2009; 121(4):187-95. PubMed ID: 19468203
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of thrombospondin receptor (CD36) in B-cell chronic lymphocytic leukemia as an indicator of tumor cell dissemination.
    Rutella S; Rumi C; Puggioni P; Barberi T; Di Mario A; Larocca LM; Leone G
    Haematologica; 1999 May; 84(5):419-24. PubMed ID: 10329920
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative expression of CD23 and its ligand CD21 in chronic lymphocytic leukemia.
    Lopez-Matas M; Rodriguez-Justo M; Morilla R; Catovsky D; Matutes E
    Haematologica; 2000 Nov; 85(11):1140-5. PubMed ID: 11064465
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD38 expression in B-chronic lymphocytic leukemia: association with clinical presentation and outcome in 155 patients.
    Domingo-Domènech E; Domingo-Clarós A; Gonzàlez-Barca E; Beneitez D; Alonso E; Romagosa V; De Sanjos S; Petit J; Grañena A; Fernández de Sevilla A
    Haematologica; 2002 Oct; 87(10):1021-7. PubMed ID: 12368155
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Natural history of chronic lymphocytic leukemia: on the progression and progression and prognosis of early clinical stages.
    Montserrat E; Viñolas N; Reverter JC; Rozman C
    Nouv Rev Fr Hematol (1978); 1988; 30(5-6):359-61. PubMed ID: 3222145
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Apoptosis in chronic lymphocytic leukemia].
    Giordano M
    Medicina (B Aires); 2000; 60 Suppl 2():12-6. PubMed ID: 11188924
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Beta-2-microglobulin levels in patients with extranodal B-cell lymphoma of the mucosa-associated lymphoid tissue (MALT)-type: a retrospective analysis.
    Penz MZ; Fiebiger WC; Valencak JB; Osterreicher C; Ba-Ssalamah A; Formanek M; Brodowic T; Chott A; Raderer M
    Anticancer Res; 2001; 21(4B):3049-52. PubMed ID: 11712809
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A review of the cytokine network in multiple myeloma: diagnostic, prognostic, and therapeutic implications.
    Lauta VM
    Cancer; 2003 May; 97(10):2440-52. PubMed ID: 12733143
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum TK levels in CLL identify Binet stage A patients within biologically defined prognostic subgroups most likely to undergo disease progression.
    Matthews C; Catherwood MA; Morris TC; Kettle PJ; Drake MB; Gilmore WS; Alexander HD
    Eur J Haematol; 2006 Oct; 77(4):309-17. PubMed ID: 16856923
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytokine and cytokine receptor serum levels in adult bone sarcoma patients: correlations with local tumor extent and prognosis.
    Rutkowski P; Kamińska J; Kowalska M; Ruka W; Steffen J
    J Surg Oncol; 2003 Nov; 84(3):151-9. PubMed ID: 14598359
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Study of interleukins and their soluble receptors in B-cell chronic lymphatic leukemia].
    Parfieńczyk A; Kiersnowska-Rogowska B; Rogowski F
    Pol Merkur Lekarski; 2004 Jan; 16(91):22-5. PubMed ID: 15074015
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased bcl-2/bax ratio in B-cell chronic lymphocytic leukemia is associated with a progressive pattern of disease.
    Molica S; Dattilo A; Giulino C; Levato D; Levato L
    Haematologica; 1998 Dec; 83(12):1122-4. PubMed ID: 9949631
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk stratification in chronic lymphocytic leukemia.
    Seiler T; Döhner H; Stilgenbauer S
    Semin Oncol; 2006 Apr; 33(2):186-94. PubMed ID: 16616065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.